Amid hurdles like competition and a dynamic consumer landscape, Medifast is taking steps to realign its strategy and ...

Medifast's collaboration with LifeMD and acquisition of LifeMD shares are expected to boost business growth and free cash flow. The company's holistic approach combining weight loss formulas ...

Medifast, Inc. MED has been strategically positioning itself to thrive in the rapidly evolving weight ... active OPTAVIA Coaches and reduced productivity per Coach. Additionally, the average ...

A new study found that women using the weight loss drug tirzepatide (Mounjaro) lost more weight than men, but experienced ...

The Danish drugmaker reported last year that a late-stage study in people who don’t have diabetes showed that the daily pill led to an average weight loss of 15% over 68 weeks, a similar result ...

Basically, the kind of medication prescribed and dosage affected the weight loss outcome. Semaglutide resulted in more than double the average weight loss of liraglutide (5.1% versus 2.2%).

At the end of the trial, average weight loss was greater with amycretin than with the placebo. Participants taking amycretin 50 mg reduced their body weight by 10.4%, on average, within 12 weeks ...